{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:15:49Z","timestamp":1793722549280,"version":"4.6.1"},"reference-count":338,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute of Dental & Craniofacial Research of the National Institutes of Health","award":["R15DE027533"],"award-info":[{"award-number":["R15DE027533"]}],"id":[{"id":"https:\/\/ror.org\/004a2wv92","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute of Dental & Craniofacial Research of the National Institutes of Health","award":["1 R56 DE029191-01A1"],"award-info":[{"award-number":["1 R56 DE029191-01A1"]}],"id":[{"id":"https:\/\/ror.org\/004a2wv92","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute of Dental & Craniofacial Research of the National Institutes of Health","award":["3R15DE027533-01A1W1"],"award-info":[{"award-number":["3R15DE027533-01A1W1"]}],"id":[{"id":"https:\/\/ror.org\/004a2wv92","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00018-022-04348-5","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T13:03:56Z","timestamp":1654607036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Biological aspects in controlling angiogenesis: current progress"],"prefix":"10.1007","volume":"79","author":[{"given":"Mohsen","family":"Akbarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz E.","family":"Bertassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-5658","authenticated-orcid":false,"given":"Lobat","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"4348_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","volume":"57","author":"J Folkman","year":"2006","unstructured":"Folkman J (2006) Angiogenesis. J Annu Rev Med 57:1\u201318","journal-title":"J Annu Rev Med"},{"issue":"8","key":"4348_CR2","doi-asserted-by":"crossref","first-page":"a005090","DOI":"10.1101\/cshperspect.a005090","volume":"3","author":"DR Senger","year":"2011","unstructured":"Senger DR, Davis GE (2011) Angiogenesis. Cold Spring Harb Perspect Biol 3(8):a005090","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"21","key":"4348_CR3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182\u20131186","journal-title":"N Engl J Med"},{"issue":"3","key":"4348_CR4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0008-6363(00)00281-9","volume":"49","author":"EM Conway","year":"2001","unstructured":"Conway EM, Collen D, Carmeliet P (2001) Molecular mechanisms of blood vessel growth. Cardiovasc Res 49(3):507\u2013521","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4348_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BCR.0b013e3181c7ed82","volume":"31","author":"AA Ucuzian","year":"2010","unstructured":"Ucuzian AA et al (2010) Molecular mediators of angiogenesis. J Burn Care 31(1):158\u2013175","journal-title":"J Burn Care"},{"issue":"10","key":"4348_CR6","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-04-2427","volume":"65","author":"P Nyberg","year":"2005","unstructured":"Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Can Res 65(10):3967\u20133979","journal-title":"Can Res"},{"issue":"2","key":"4348_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2005.04.008","volume":"236","author":"A Mart\u00ednez","year":"2006","unstructured":"Mart\u00ednez A (2006) A new family of angiogenic factors. Cancer Lett 236(2):157\u2013163","journal-title":"Cancer Lett"},{"issue":"2","key":"4348_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ydbio.2012.09.018","volume":"372","author":"D Ribatti","year":"2012","unstructured":"Ribatti D, Crivellato E (2012) \u201cSprouting angiogenesis\u201d, a reappraisal. Dev Biol 372(2):157\u2013165","journal-title":"Dev Biol"},{"issue":"8","key":"4348_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/abbs\/40.8.681","volume":"40","author":"W Cai","year":"2008","unstructured":"Cai W, Schaper W (2008) Mechanisms of arteriogenesis. Acta Biochim Biophys Sin 40(8):681\u2013692","journal-title":"Acta Biochim Biophys Sin"},{"issue":"12","key":"4348_CR10","first-page":"1117","volume":"2","author":"BL Krock","year":"2011","unstructured":"Krock BL et al (2011) Hypoxia-induced angiogenesis: good and evil. Genes 2(12):1117\u20131133","journal-title":"Genes"},{"issue":"5","key":"4348_CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"A-K Olsson","year":"2006","unstructured":"Olsson A-K et al (2006) VEGF receptor signalling? In control of vascular function. Nat Rev Mol Cell Biol 7(5):359\u2013371","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4348_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/eje.0.1460143","volume":"146","author":"HM Stepien","year":"2002","unstructured":"Stepien HM et al (2002) Angiogenesis of endocrine gland tumours-new molecular targets in diagnostics and therapy. Eur J Endocrinol 146(2):143\u2013152","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"4348_CR13","first-page":"2824","volume":"62","author":"M Trikha","year":"2002","unstructured":"Trikha M et al (2002) Multiple roles for platelet GPIIb\/IIIa and \u03b1v\u03b23 integrins in tumor growth, angiogenesis, and metastasis. Can Res 62(10):2824\u20132833","journal-title":"Can Res"},{"key":"4348_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386503-8.00002-8","volume":"114","author":"O Salvucci","year":"2012","unstructured":"Salvucci O, Tosato G (2012) Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 114:21\u201357","journal-title":"Adv Cancer Res"},{"key":"4348_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","volume":"57","author":"J Folkman","year":"2006","unstructured":"Folkman J (2006) Angiogenesis. Annu Rev Med 57:1\u201318","journal-title":"Annu Rev Med"},{"issue":"7347","key":"4348_CR16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298\u2013307","journal-title":"Nature"},{"issue":"19","key":"4348_CR17","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358(19):2039\u20132049","journal-title":"N Engl J Med"},{"key":"4348_CR18","volume":"7","author":"EA Shikatani","year":"2012","unstructured":"Shikatani EA et al (2012) Inhibition of proliferation, migration and proteolysis contribute to corticosterone-mediated inhibition of angiogenesis. PLoS\u00a0One 7:e46625","journal-title":"PLoS\u00a0One"},{"issue":"9","key":"4348_CR19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.24886","volume":"126","author":"M Pasquet","year":"2010","unstructured":"Pasquet M et al (2010) Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer 126(9):2090\u20132101","journal-title":"Int J Cancer"},{"key":"4348_CR20","first-page":"45","volume-title":"Stem cells and cancer stem cells","author":"AC Dudley","year":"2012","unstructured":"Dudley AC, Cloer EW, Melero-Martin JM (2012) The role of bone marrow-derived progenitor cells in tumor growth and angiogenesis. Stem cells and cancer stem cells, vol 8. Springer, pp 45\u201354"},{"issue":"6","key":"4348_CR21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717\u2013727","journal-title":"Eur J Cancer"},{"issue":"1","key":"4348_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0423-7","volume":"25","author":"CR Harrell","year":"2018","unstructured":"Harrell CR et al (2018) Molecular mechanisms underlying therapeutic potential of pericytes. J Biomed Sci 25(1):1\u201312","journal-title":"J Biomed Sci"},{"issue":"3","key":"4348_CR23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0026-2862(79)90041-4","volume":"18","author":"RG Tilton","year":"1979","unstructured":"Tilton RG, Kilo C, Williamson JR (1979) Pericyte-endothelial relationships in cardiac and skeletal muscle capillaries. Microvasc Res 18(3):325\u2013335","journal-title":"Microvasc Res"},{"issue":"11","key":"4348_CR24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.7.11.8370472","volume":"7","author":"D Shepro","year":"1993","unstructured":"Shepro D, Morel NM (1993) Pericyte physiology. FASEB J 7(11):1031\u20131038","journal-title":"FASEB J"},{"issue":"5","key":"4348_CR25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","volume":"29","author":"K Gaengel","year":"2009","unstructured":"Gaengel K et al (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29(5):630\u2013638","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"19","key":"4348_CR26","volume":"22","author":"S Lee","year":"2010","unstructured":"Lee S et al (2010) Pericyte actomyosin-mediated contraction at the cell\u2013material interface can modulate the microvascular niche. J Phys Condens Matter 22(19):194115","journal-title":"J Phys Condens Matter"},{"issue":"2","key":"4348_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/stem.1285","volume":"31","author":"CW Chen","year":"2013","unstructured":"Chen CW et al (2013) Human pericytes for ischemic heart repair. Stem Cells 31(2):305\u2013316","journal-title":"Stem Cells"},{"issue":"6","key":"4348_CR28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1084\/jem.20111622","volume":"209","author":"D Proebstl","year":"2012","unstructured":"Proebstl D et al (2012) Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 209(6):1219\u20131234","journal-title":"J Exp Med"},{"key":"4348_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-319-95294-9_6","volume":"1092","author":"MR Zanotelli","year":"2018","unstructured":"Zanotelli MR, Reinhart-King CA (2018) Mechanical forces in tumor angiogenesis. Adv Exp Med Biol 1092:91\u2013112. https:\/\/doi.org\/10.1007\/978-3-319-95294-9_6","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"4348_CR30","doi-asserted-by":"crossref","first-page":"H152","DOI":"10.1152\/ajpheart.00995.2013","volume":"307","author":"CJ Underwood","year":"2014","unstructured":"Underwood CJ et al (2014) Cell-generated traction forces and the resulting matrix deformation modulate microvascular alignment and growth during angiogenesis. Am J Physiol Heart Circ Physiol 307(2):H152\u2013H164","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"4348_CR31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0955-0674(98)80145-2","volume":"10","author":"ME Chicurel","year":"1998","unstructured":"Chicurel ME, Chen CS, Ingber DE (1998) Cellular control lies in the balance of forces. Curr Opin Cell Biol 10(2):232\u2013239","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"4348_CR32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0955-0674(98)80030-6","volume":"10","author":"CG Galbraith","year":"1998","unstructured":"Galbraith CG, Sheetz MP (1998) Forces on adhesive contacts affect cell function. Curr Opin Cell Biol 10(5):566\u2013571","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"4348_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yexcr.2004.03.035","volume":"297","author":"A Sieminski","year":"2004","unstructured":"Sieminski A, Hebbel R, Gooch K (2004) The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp Cell Res 297(2):574\u2013584","journal-title":"Exp Cell Res"},{"issue":"2","key":"4348_CR34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/excr.1996.0234","volume":"226","author":"M Kuzuya","year":"1996","unstructured":"Kuzuya M et al (1996) Inhibition of endothelial cell differentiation on a glycosylated reconstituted basement membrane complex. Exp Cell Res 226(2):336\u2013345","journal-title":"Exp Cell Res"},{"issue":"3","key":"4348_CR35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0008-6363(00)00233-9","volume":"49","author":"CF Deroanne","year":"2001","unstructured":"Deroanne CF, Lapiere CM, Nusgens BV (2001) In vitro tubulogenesis of endothelial cells by relaxation of the coupling extracellular matrix-cytoskeleton. Cardiovasc Res 49(3):647\u2013658","journal-title":"Cardiovasc Res"},{"issue":"2","key":"4348_CR36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02633972","volume":"31","author":"RB Vernon","year":"1995","unstructured":"Vernon RB et al (1995) Organized type I collagen influences endothelial patterns during \u201cspontaneous angiogenesis in vitro\u201d: planar cultures as models of vascular development. In Vitro Cell Dev Biol Anim 31(2):120\u2013131","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"4348_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0026-2862(77)90141-8","volume":"14","author":"DH Ausprunk","year":"1977","unstructured":"Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14(1):53\u201365","journal-title":"Microvasc Res"},{"issue":"5","key":"4348_CR38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1615\/CritRevBiomedEng.v33.i5.10","volume":"33","author":"Y-T Shiu","year":"2005","unstructured":"Shiu Y-T et al (2005) The role of mechanical stresses in angiogenesis. Crit Rev Biomed Eng 33(5):431\u2013510","journal-title":"Crit Rev Biomed Eng"},{"issue":"5","key":"4348_CR39","first-page":"536","volume":"66","author":"RB Vernon","year":"1992","unstructured":"Vernon RB et al (1992) Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro. Lab Investig 66(5):536\u2013547","journal-title":"Lab Investig"},{"issue":"4","key":"4348_CR40","first-page":"873","volume":"147","author":"RB Vernon","year":"1995","unstructured":"Vernon RB, Sage EH (1995) Between molecules and morphology. Extracellular matrix and creation of vascular form. Am J Pathol 147(4):873","journal-title":"Am J Pathol"},{"issue":"3","key":"4348_CR41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/physrev.1995.75.3.519","volume":"75","author":"PF Davies","year":"1995","unstructured":"Davies PF (1995) Flow-mediated endothelial mechanotransduction. Physiol Rev 75(3):519\u2013560","journal-title":"Physiol Rev"},{"key":"4348_CR42","unstructured":"Krishnan L et al (2003) Effects of angiogenesis on the material properties of the extracellular matrix: correlation with gene expression. In: Proceedings of the ASME summer bioengineering conference"},{"issue":"1","key":"4348_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/aja.1000230103","volume":"23","author":"ER Clark","year":"1918","unstructured":"Clark ER (1918) Studies on the growth of blood-vessels in the tail of the frog larva\u2014by observation and experiment on the living animal. Am J Anat 23(1):37\u201388","journal-title":"Am J Anat"},{"issue":"4","key":"4348_CR44","doi-asserted-by":"crossref","first-page":"H1430","DOI":"10.1152\/ajpheart.00082.2002","volume":"283","author":"I Rivilis","year":"2002","unstructured":"Rivilis I et al (2002) Differential involvement of MMP-2 and VEGF during muscle stretch-versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 283(4):H1430\u2013H1438","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"4348_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/713774014","volume":"8","author":"EJ Van Gieson","year":"2001","unstructured":"Van Gieson EJ, Skalak TC (2001) Chronic vasodilation induces matrix metalloproteinase 9 (MMP-9) expression during microvascular remodeling in rat skeletal muscle. Microcirculation 8(1):25\u201331","journal-title":"Microcirculation"},{"issue":"3","key":"4348_CR46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0008-6363(00)00282-0","volume":"49","author":"S Egginton","year":"2001","unstructured":"Egginton S et al (2001) Unorthodox angiogenesis in skeletal muscle. Cardiovasc Res 49(3):634\u2013646","journal-title":"Cardiovasc Res"},{"issue":"6","key":"4348_CR47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1152\/jappl.1998.85.6.2025","volume":"85","author":"S Egginton","year":"1998","unstructured":"Egginton S et al (1998) Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle. J Appl Physiol 85(6):2025\u20132032","journal-title":"J Appl Physiol"},{"issue":"8","key":"4348_CR48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejim.2003.10.003","volume":"14","author":"A Bamias","year":"2003","unstructured":"Bamias A, Dimopoulos MA (2003) Angiogenesis in human cancer: implications in cancer therapy. Eur J Intern Med 14(8):459\u2013469","journal-title":"Eur J Intern Med"},{"issue":"6","key":"4348_CR49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3748\/wjg.v9.i6.1144","volume":"9","author":"MK Gupta","year":"2003","unstructured":"Gupta MK, Qin R-Y (2003) Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol WJG 9(6):1144","journal-title":"World J Gastroenterol WJG"},{"key":"4348_CR50","first-page":"37","volume":"146","author":"AT Hertig","year":"1935","unstructured":"Hertig AT (1935) Angiogenesis in the early human chorion and in the primary placenta of the macaque monkey. Control Embryol 146:37\u201382","journal-title":"Control Embryol"},{"issue":"5309","key":"4348_CR51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.276.5309.75","volume":"276","author":"P Martin","year":"1997","unstructured":"Martin P (1997) Wound healing\u2013aiming for perfect skin regeneration. Science 276(5309):75\u201381","journal-title":"Science"},{"key":"4348_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4899-0185-9_1","volume-title":"The molecular and cellular biology of wound repair","author":"RA Clark","year":"1988","unstructured":"Clark RA (1988) Wound repair. The molecular and cellular biology of wound repair. Springer, New York, pp 3\u201350"},{"issue":"4","key":"4348_CR53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0891-8422(02)00018-6","volume":"19","author":"S Albert","year":"2002","unstructured":"Albert S (2002) Cost-effective management of recalcitrant diabetic foot ulcers. Clin Podiatr Med 19(4):483\u2013491","journal-title":"Clin Podiatr Med"},{"issue":"4","key":"4348_CR54","first-page":"390","volume":"12","author":"J Kanitakis","year":"2002","unstructured":"Kanitakis J (2002) Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol 12(4):390\u2013401","journal-title":"Eur J Dermatol"},{"issue":"1","key":"4348_CR55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000441-199307000-00011","volume":"306","author":"RA Clark","year":"1993","unstructured":"Clark RA (1993) Regulation of fibroplasia in cutaneous wound repair. Am J Med Sci 306(1):42\u201348","journal-title":"Am J Med Sci"},{"issue":"6","key":"4348_CR56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrm1665","volume":"6","author":"PL McNeil","year":"2005","unstructured":"McNeil PL, Kirchhausen T (2005) An emergency response team for membrane repair. Nat Rev Mol Cell Biol 6(6):499\u2013505","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4348_CR57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiolgenomics.00045.2008","volume":"34","author":"S Roy","year":"2008","unstructured":"Roy S et al (2008) Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genom 34(2):162\u2013184","journal-title":"Physiol Genom"},{"issue":"8","key":"4348_CR58","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/jid.2008.34","volume":"128","author":"C-F Cheng","year":"2008","unstructured":"Cheng C-F et al (2008) Profiling motility signal-specific genes in primary human keratinocytes. J Investig Dermatol 128(8):1981\u20131990","journal-title":"J Investig Dermatol"},{"issue":"7142","key":"4348_CR59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05766","volume":"447","author":"M Ito","year":"2007","unstructured":"Ito M et al (2007) Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447(7142):316\u2013320","journal-title":"Nature"},{"issue":"2\u20133","key":"4348_CR60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mvr.2007.04.008","volume":"74","author":"CM Becker","year":"2007","unstructured":"Becker CM, D\u2019Amato RJ (2007) Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 74(2\u20133):121\u2013130","journal-title":"Microvasc Res"},{"issue":"3","key":"4348_CR61","first-page":"245","volume":"60","author":"K May","year":"2008","unstructured":"May K, Becker C (2008) Endometriosis and angiogenesis. Minerva Ginecol 60(3):245\u2013254","journal-title":"Minerva Ginecol"},{"key":"4348_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/179515","volume":"2014","author":"S Sourial","year":"2014","unstructured":"Sourial S, Tempest N, Hapangama DK (2014) Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014:1\u20139","journal-title":"Int J Reprod Med"},{"issue":"Suppl. 1","key":"4348_CR63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000049425","volume":"53","author":"CA Witz","year":"2002","unstructured":"Witz CA (2002) Pathogenesis of endometriosis. Gynecol Obstet Investig 53(Suppl. 1):52\u201362","journal-title":"Gynecol Obstet Investig"},{"issue":"1","key":"4348_CR64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/oxfordjournals.humrep.a019023","volume":"11","author":"J McLaren","year":"1996","unstructured":"McLaren J et al (1996) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 11(1):220\u2013223","journal-title":"Hum Reprod"},{"issue":"1","key":"4348_CR65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0015-0282(00)00555-0","volume":"74","author":"MD Mueller","year":"2000","unstructured":"Mueller MD et al (2000) Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 74(1):107\u2013112","journal-title":"Fertil Steril"},{"issue":"12","key":"4348_CR66","first-page":"3183","volume":"60","author":"SM Hyder","year":"2000","unstructured":"Hyder SM et al (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60(12):3183\u20133190","journal-title":"Cancer Res"},{"issue":"6","key":"4348_CR67","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1210\/jc.2002-021912","volume":"88","author":"ML Hull","year":"2003","unstructured":"Hull ML et al (2003) Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88(6):2889\u20132899","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"4348_CR68","first-page":"2109","volume":"34","author":"J Folkman","year":"1974","unstructured":"Folkman J (1974) Tumor angiogenesis factor. Can Res 34(8):2109\u20132113","journal-title":"Can Res"},{"issue":"5777","key":"4348_CR69","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1125950","volume":"312","author":"RS Kerbel","year":"2006","unstructured":"Kerbel RS (2006) Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science 312(5777):1171\u20131175","journal-title":"Science"},{"issue":"12","key":"4348_CR70","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/phar.1147","volume":"32","author":"B Al-Husein","year":"2012","unstructured":"Al-Husein B et al (2012) Antiangiogenic therapy for cancer: an update. Pharmacother J Hum Pharmacol Drug Ther 32(12):1095\u20131111","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"954","key":"4348_CR71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/pgmj.2004.023309","volume":"81","author":"K Gupta","year":"2005","unstructured":"Gupta K, Zhang J (2005) Angiogenesis: a curse or cure? Postgrad Med J 81(954):236\u2013242","journal-title":"Postgrad Med J"},{"issue":"10","key":"4348_CR72","first-page":"3527","volume":"91","author":"DB Cines","year":"1998","unstructured":"Cines DB et al (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood J Am Soc Hematol 91(10):3527\u20133561","journal-title":"Blood J Am Soc Hematol"},{"issue":"15","key":"4348_CR73","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1158\/0008-5472.CAN-07-0293","volume":"67","author":"B Sennino","year":"2007","unstructured":"Sennino B et al (2007) Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Can Res 67(15):7358\u20137367","journal-title":"Can Res"},{"issue":"2","key":"4348_CR74","first-page":"237","volume":"52","author":"AW Griffioen","year":"2000","unstructured":"Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52(2):237\u2013268","journal-title":"Pharmacol Rev"},{"issue":"11","key":"4348_CR75","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI1560","volume":"101","author":"T Murohara","year":"1998","unstructured":"Murohara T et al (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Investig 101(11):2567\u20132578","journal-title":"J Clin Investig"},{"issue":"5","key":"4348_CR76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vph.2006.01.005","volume":"44","author":"NM Pandya","year":"2006","unstructured":"Pandya NM, Dhalla NS, Santani DD (2006) Angiogenesis\u2014a new target for future therapy. Vasc Pharmacol 44(5):265\u2013274","journal-title":"Vasc Pharmacol"},{"issue":"4","key":"4348_CR77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/156800908784533481","volume":"8","author":"M Furuya","year":"2008","unstructured":"Furuya M, Yonemitsu Y (2008) Cancer neovascularization and proinflammatory microenvironments. Curr Cancer Drug Targets 8(4):253\u2013265","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"4348_CR78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/vhrm.2005.1.4.277","volume":"1","author":"M Furuya","year":"2005","unstructured":"Furuya M et al (2005) Pathophysiology of tumor neovascularization. Vasc Health Risk Manag Healthc Policy 1(4):277","journal-title":"Vasc Health Risk Manag Healthc Policy"},{"issue":"1","key":"4348_CR79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2006.06.007","volume":"248","author":"D Ribatti","year":"2007","unstructured":"Ribatti D et al (2007) The structure of the vascular network of tumors. Cancer Lett 248(1):18\u201323","journal-title":"Cancer Lett"},{"issue":"5482","key":"4348_CR80","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","volume":"289","author":"BS Croix","year":"2000","unstructured":"Croix BS et al (2000) Genes expressed in human tumor endothelium. Science 289(5482):1197\u20131202","journal-title":"Science"},{"issue":"21","key":"4348_CR81","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1158\/0008-5472.CAN-04-1976","volume":"64","author":"BS Parker","year":"2004","unstructured":"Parker BS et al (2004) Alterations in vascular gene expression in invasive breast carcinoma. Can Res 64(21):7857\u20137866","journal-title":"Can Res"},{"issue":"2","key":"4348_CR82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)63324-X","volume":"165","author":"SL Madden","year":"2004","unstructured":"Madden SL et al (2004) Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol 165(2):601\u2013608","journal-title":"Am J Pathol"},{"issue":"8","key":"4348_CR83","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2005.01361.x","volume":"3","author":"H Dvorak","year":"2005","unstructured":"Dvorak H (2005) Angiogenesis: update 2005. J Thromb Haemost 3(8):1835\u20131842","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4348_CR84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biomedicines5020034","volume":"5","author":"M Rajabi","year":"2017","unstructured":"Rajabi M, Mousa SA (2017) The role of angiogenesis in cancer treatment. Biomedicines 5(2):34","journal-title":"Biomedicines"},{"issue":"7","key":"4348_CR85","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20041896","volume":"201","author":"S Hirakawa","year":"2005","unstructured":"Hirakawa S et al (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201(7):1089\u20131099","journal-title":"J Exp Med"},{"issue":"3","key":"4348_CR86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida N et al (2006) Angiogenesis in cancer. Vasc Health Risk Manag Healthc Policy 2(3):213","journal-title":"Vasc Health Risk Manag Healthc Policy"},{"issue":"3","key":"4348_CR87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.hoc.2009.03.007","volume":"23","author":"AG Marneros","year":"2009","unstructured":"Marneros AG (2009) Tumor angiogenesis in melanoma. Hematol Oncol Clin 23(3):431\u2013446","journal-title":"Hematol Oncol Clin"},{"issue":"4","key":"4348_CR88","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/2159-8290.CD-11-0280","volume":"2","author":"MJ Martin","year":"2012","unstructured":"Martin MJ et al (2012) Metformin accelerates the growth of BRAFV600E-driven melanoma by upregulating VEGF-A. Cancer Discov 2(4):344\u2013355","journal-title":"Cancer Discov"},{"issue":"5","key":"4348_CR89","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3892\/or.2015.4228","volume":"34","author":"M Stec","year":"2015","unstructured":"Stec M et al (2015) Isolation and characterization of circulating micro (nano) vesicles in the plasma of colorectal cancer patients and their interactions with tumor cells. Oncol Rep 34(5):2768\u20132775","journal-title":"Oncol Rep"},{"issue":"11","key":"4348_CR90","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.3390\/ijms21113946","volume":"21","author":"W Olejarz","year":"2020","unstructured":"Olejarz W, \u0141acheta D, Kubiak-Tomaszewska G (2020) Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability. Int J Mol Sci 21(11):3946","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4348_CR91","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470\u20131476","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4348_CR92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbadis.2015.09.020","volume":"1862","author":"KM Kanninen","year":"2016","unstructured":"Kanninen KM et al (2016) Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta Mol Basis Dis 1862(3):403\u2013410","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"4348_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5704\/MOJ.1903.012","volume":"13","author":"A Esa","year":"2019","unstructured":"Esa A et al (2019) Extracellular vesicles in the synovial joint: is there a role in the pathophysiology of osteoarthritis? Malays Orthop J 13(1):1","journal-title":"Malays Orthop J"},{"issue":"1","key":"4348_CR94","doi-asserted-by":"crossref","first-page":"1629865","DOI":"10.1080\/20013078.2019.1629865","volume":"8","author":"Y Zeng","year":"2019","unstructured":"Zeng Y et al (2019) Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles 8(1):1629865","journal-title":"J Extracell Vesicles"},{"key":"4348_CR95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acc.2015.12.005","volume":"74","author":"TL Whiteside","year":"2016","unstructured":"Whiteside TL (2016) Tumor-derived exosomes and their role in cancer progression. Adv Clin Chem 74:103\u2013141","journal-title":"Adv Clin Chem"},{"issue":"8","key":"4348_CR96","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7150\/ijbs.11943","volume":"11","author":"A Huang","year":"2015","unstructured":"Huang A et al (2015) Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells. Int J Biol Sci 11(8):961","journal-title":"Int J Biol Sci"},{"issue":"5","key":"4348_CR97","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"L Qu","year":"2016","unstructured":"Qu L et al (2016) Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell 29(5):653\u2013668","journal-title":"Cancer Cell"},{"issue":"3","key":"4348_CR98","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.addr.2012.07.001","volume":"65","author":"RWY Yeo","year":"2013","unstructured":"Yeo RWY et al (2013) Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev 65(3):336\u2013341","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4348_CR99","first-page":"1","volume":"10","author":"B Chen","year":"2019","unstructured":"Chen B et al (2019) Human embryonic stem cell-derived exosomes promote pressure ulcer healing in aged mice by rejuvenating senescent endothelial cells. Stem Cell Res 10(1):1\u201317","journal-title":"Stem Cell Res"},{"issue":"1","key":"4348_CR100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152207779802536","volume":"7","author":"J Waltenberger","year":"2007","unstructured":"Waltenberger J (2007) New horizons in diabetes therapy: the angiogenesis paradox in diabetes: description of the problem and presentation of a unifying hypothesis. Immunol Endocr Metab Agents Med Chem 7(1):87\u201393","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"issue":"2","key":"4348_CR101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/med.10024","volume":"23","author":"A Martin","year":"2003","unstructured":"Martin A, Komada MR, Sane DC (2003) Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23(2):117\u2013145","journal-title":"Med Res Rev"},{"issue":"1","key":"4348_CR102","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11154-015-9310-7","volume":"16","author":"R Cheng","year":"2015","unstructured":"Cheng R, Ma J-X (2015) Angiogenesis in diabetes and obesity. Rev Endocr Metab Disord 16(1):67\u201375","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"4348_CR103","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/ijms18071419","volume":"18","author":"UA Okonkwo","year":"2017","unstructured":"Okonkwo UA, DiPietro LA (2017) Diabetes and wound angiogenesis. Int J Mol Sci 18(7):1419","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4348_CR104","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4","volume":"261","author":"RJ Tomanek","year":"2000","unstructured":"Tomanek RJ, Schatteman GC (2000) Angiogenesis: new insights and therapeutic potential. Anat Rec 261(3):126\u2013135","journal-title":"Anat Rec"},{"issue":"17","key":"4348_CR105","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.99.17.2239","volume":"99","author":"A Abac\u0131","year":"1999","unstructured":"Abac\u0131 A et al (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99(17):2239\u20132242","journal-title":"Circulation"},{"issue":"23","key":"4348_CR106","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1161\/hc4801.100352","volume":"104","author":"GS Werner","year":"2001","unstructured":"Werner GS et al (2001) Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 104(23):2784\u20132790","journal-title":"Circulation"},{"key":"4348_CR107","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.2147\/DMSO.S315362","volume":"14","author":"S Tan","year":"2021","unstructured":"Tan S et al (2021) Differences of angiogenesis factors in tumor and diabetes mellitus. Diabetes Metab Syndr Obes Targets Ther 14:3375","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"4348_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/918267","volume":"2012","author":"GK Kolluru","year":"2012","unstructured":"Kolluru GK, Bir SC, Kevil CG (2012) Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012:1\u201330","journal-title":"Int J Vasc Med"},{"key":"4348_CR109","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","volume":"27","author":"AS Chung","year":"2011","unstructured":"Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol (New York, N.Y.: 1985) 27:563\u2013584","journal-title":"Annu Rev Cell Dev Biol (New York, N.Y.: 1985)"},{"issue":"12","key":"4348_CR110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/jhh.2009.63","volume":"23","author":"R Humar","year":"2009","unstructured":"Humar R, Zimmerli L, Battegay E (2009) Angiogenesis and hypertension: an update. J Hum Hypertens 23(12):773\u2013782","journal-title":"J Hum Hypertens"},{"issue":"4","key":"4348_CR111","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/157016112800812836","volume":"10","author":"P Ferroni","year":"2012","unstructured":"Ferroni P et al (2012) Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies. Curr Vasc Pharmacol 10(4):479\u2013493","journal-title":"Curr Vasc Pharmacol"},{"issue":"5","key":"4348_CR112","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","volume":"349","author":"JC Yang","year":"2003","unstructured":"Yang JC et al (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349(5):427\u2013434","journal-title":"N Engl J Med"},{"issue":"1","key":"4348_CR113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0895-7061(02)03149-7","volume":"16","author":"DC Felmeden","year":"2003","unstructured":"Felmeden DC et al (2003) Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 16(1):11\u201320","journal-title":"Am J Hypertens"},{"issue":"3","key":"4348_CR114","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10456-004-2699-3","volume":"7","author":"DC Sane","year":"2004","unstructured":"Sane DC, Anton L, Brosnihan KB (2004) Angiogenic growth factors and hypertension. Angiogenesis 7(3):193\u2013201","journal-title":"Angiogenesis"},{"issue":"3","key":"4348_CR115","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/hy0302.105398","volume":"39","author":"R Yang","year":"2002","unstructured":"Yang R et al (2002) Exaggerated hypotensive effect of vascular endothelial growth factor in spontaneously hypertensive rats. Hypertension 39(3):815\u2013820","journal-title":"Hypertension"},{"issue":"2","key":"4348_CR116","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2007.07.010","volume":"130","author":"V Vila","year":"2008","unstructured":"Vila V et al (2008) Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients. Int J Cardiol 130(2):276\u2013277","journal-title":"Int J Cardiol"},{"issue":"2","key":"4348_CR117","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.yexcr.2004.06.032","volume":"300","author":"FN Kiefer","year":"2004","unstructured":"Kiefer FN et al (2004) A versatile in vitro assay for investigating angiogenesis of the heart. Exp Cell Res 300(2):272\u2013282","journal-title":"Exp Cell Res"},{"issue":"4","key":"4348_CR118","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.acthis.2006.09.005","volume":"108","author":"TM Grass","year":"2006","unstructured":"Grass TM, Lurie DI, Coffin JD (2006) Transitional angiogenesis and vascular remodeling during coronary angiogenesis in response to myocardial infarction. Acta Histochem 108(4):293\u2013302","journal-title":"Acta Histochem"},{"issue":"8","key":"4348_CR119","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tibtech.2008.04.009","volume":"26","author":"J Rouwkema","year":"2008","unstructured":"Rouwkema J, Rivron NC, van Blitterswijk CA (2008) Vascularization in tissue engineering. Trends Biotechnol 26(8):434\u2013441","journal-title":"Trends Biotechnol"},{"issue":"6","key":"4348_CR120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm2183","volume":"8","author":"RH Adams","year":"2007","unstructured":"Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8(6):464\u2013478","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4348_CR121","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/ten.teb.2008.0193","volume":"15","author":"T Kaully","year":"2009","unstructured":"Kaully T et al (2009) Vascularization\u2014the conduit to viable engineered tissues. Tissue Eng Part B Rev 15(2):159\u2013169","journal-title":"Tissue Eng Part B Rev"},{"key":"4348_CR122","doi-asserted-by":"crossref","DOI":"10.1002\/9781118886410","volume-title":"Introduction to tissue engineering: applications and challenges","author":"R Birla","year":"2014","unstructured":"Birla R (2014) Introduction to tissue engineering: applications and challenges. Wiley, Hoboken"},{"issue":"4","key":"4348_CR123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00063030-200822040-00001","volume":"22","author":"P Atluri","year":"2008","unstructured":"Atluri P, Woo YJ (2008) Pro-angiogenic cytokines as cardiovascular therapeutics. BioDrugs 22(4):209\u2013222","journal-title":"BioDrugs"},{"issue":"1","key":"4348_CR124","first-page":"1","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang Y et al (2018) New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer 17(1):1\u201310","journal-title":"Mol Cancer"},{"issue":"6","key":"4348_CR125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber H-P, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669\u2013676","journal-title":"Nat Med"},{"issue":"Suppl. 3","key":"4348_CR126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl. 3):4\u201310","journal-title":"Oncology"},{"issue":"5","key":"4348_CR127","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.neo.7900186","volume":"3","author":"ML George","year":"2001","unstructured":"George ML et al (2001) Vegf-a, vegf-c, and vegf-d in colorectal cancer progression. Neoplasia 3(5):420\u2013427","journal-title":"Neoplasia"},{"issue":"4","key":"4348_CR128","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1073\/pnas.96.4.1246","volume":"96","author":"I Struman","year":"1999","unstructured":"Struman I et al (1999) Opposing actions of intact and N-terminal fragments of the human prolactin\/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci 96(4):1246\u20131251","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4348_CR129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben A et al (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56(4):549\u2013580","journal-title":"Pharmacol Rev"},{"issue":"10","key":"4348_CR130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen TT et al (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92(10):1098\u20131106","journal-title":"Circ Res"},{"issue":"47","key":"4348_CR131","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.3748\/wjg.v12.i47.7598","volume":"12","author":"H-C Zhao","year":"2006","unstructured":"Zhao H-C et al (2006) Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol WJG 12(47):7598","journal-title":"World J Gastroenterol WJG"},{"issue":"6","key":"4348_CR132","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1010-7940(01)01000-4","volume":"20","author":"H Huwer","year":"2001","unstructured":"Huwer H et al (2001) Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease. Eur J Cardiothorac Surg 20(6):1128\u20131134","journal-title":"Eur J Cardiothorac Surg"},{"issue":"8","key":"4348_CR133","first-page":"384","volume":"28","author":"T Celik","year":"2005","unstructured":"Celik T et al (2005) Impaired coronary collateral vessel development in patients with proliferative diabetic retinopathy. Clin Cardiol Int Index Peer Rev J Adv Treat Cardiovasc Dis 28(8):384\u2013388","journal-title":"Clin Cardiol Int Index Peer Rev J Adv Treat Cardiovasc Dis"},{"issue":"3","key":"4348_CR134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/hc0302.102143","volume":"105","author":"E Chou","year":"2002","unstructured":"Chou E et al (2002) Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105(3):373\u2013379","journal-title":"Circulation"},{"key":"4348_CR135","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1046\/j.1523-1755.2000.07718.x","volume":"58","author":"LP Aiello","year":"2000","unstructured":"Aiello LP, Wong J-S (2000) Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 58:S113\u2013S119","journal-title":"Kidney Int"},{"issue":"6","key":"4348_CR136","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11892-008-0081-3","volume":"8","author":"S Chen","year":"2008","unstructured":"Chen S, Ziyadeh FN (2008) Vascular endothelial growth factor and diabetic nephropathy. Curr Diabetes Rep 8(6):470\u2013476","journal-title":"Curr Diabetes Rep"},{"issue":"6","key":"4348_CR137","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00401-007-0228-3","volume":"113","author":"S Raab","year":"2007","unstructured":"Raab S, Plate KH (2007) Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system. Acta Neuropathol 113(6):607\u2013626","journal-title":"Acta Neuropathol"},{"issue":"6","key":"4348_CR138","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9(6):653\u2013660","journal-title":"Nat Med"},{"issue":"35","key":"4348_CR139","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.2174\/138161207782794158","volume":"13","author":"H Hall","year":"2007","unstructured":"Hall H (2007) Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. Curr Pharm Des 13(35):3597\u20133607","journal-title":"Curr Pharm Des"},{"key":"4348_CR140","volume":"55","author":"S Peng","year":"2021","unstructured":"Peng S et al (2021) LncRNA-AK137033 inhibits the osteogenic potential of adipose-derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation. Cell Prolif 55:e13174","journal-title":"Cell Prolif"},{"key":"4348_CR141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.actbio.2019.08.047","volume":"99","author":"J Son","year":"2019","unstructured":"Son J et al (2019) DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration. Acta Biomater 99:469\u2013478","journal-title":"Acta Biomater"},{"issue":"3","key":"4348_CR142","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.peptides.2006.11.008","volume":"28","author":"B Hardy","year":"2007","unstructured":"Hardy B et al (2007) Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions. Peptides 28(3):691\u2013701","journal-title":"Peptides"},{"issue":"9498","key":"4348_CR143","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(05)67699-4","volume":"366","author":"PR Cavanagh","year":"2005","unstructured":"Cavanagh PR et al (2005) Treatment for diabetic foot ulcers. Lancet 366(9498):1725\u20131735","journal-title":"Lancet"},{"key":"4348_CR144","first-page":"102","volume":"3","author":"AH Van Hove","year":"2015","unstructured":"Van Hove AH, Benoit DS (2015) Depot-based delivery systems for pro-angiogenic peptides: a review. Front Bioeng Biotechnol Adv 3:102","journal-title":"Front Bioeng Biotechnol Adv"},{"issue":"8","key":"4348_CR145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1163\/156856208784909435","volume":"19","author":"L Pickart","year":"2008","unstructured":"Pickart L (2008) The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 19(8):969\u2013988","journal-title":"J Biomater Sci Polym Ed"},{"issue":"48","key":"4348_CR146","doi-asserted-by":"crossref","first-page":"30517","DOI":"10.1074\/jbc.271.48.30517","volume":"271","author":"AL Akeson","year":"1996","unstructured":"Akeson AL et al (1996) AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem 271(48):30517\u201330523","journal-title":"J Biol Chem"},{"issue":"4","key":"4348_CR147","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1900\/RDS.2012.9.338","volume":"9","author":"T Mandrup-Poulsen","year":"2012","unstructured":"Mandrup-Poulsen T (2012) Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes. Rev Diabet Stud RDS 9(4):338","journal-title":"Rev Diabet Stud RDS"},{"issue":"24","key":"4348_CR148","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1158\/0008-5472.CAN-04-2172","volume":"64","author":"A-K Olsson","year":"2004","unstructured":"Olsson A-K et al (2004) The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization. Can Res 64(24):9012\u20139017","journal-title":"Can Res"},{"key":"4348_CR149","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.maturitas.2016.12.003","volume":"97","author":"CK Chew","year":"2017","unstructured":"Chew CK, Clarke BL (2017) Abaloparatide: recombinant human PTHrP (1\u201334) anabolic therapy for osteoporosis. Maturitas 97:53\u201360","journal-title":"Maturitas"},{"issue":"suppl_3","key":"4348_CR150","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1093\/cid\/cir920","volume":"54","author":"GG Zhanel","year":"2012","unstructured":"Zhanel GG, Schweizer F, Karlowsky JA (2012) Oritavancin: mechanism of action. Clin Infect Dis 54(suppl_3):S214\u2013S219","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4348_CR151","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bcp.2012.04.011","volume":"84","author":"F Finetti","year":"2012","unstructured":"Finetti F et al (2012) Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis. Biochem Pharmacol 84(3):303\u2013311","journal-title":"Biochem Pharmacol"},{"key":"4348_CR152","unstructured":"Slyke P, Dumont D (2011) Multimeric TIE 2 agonists and uses thereof in stimulating angiogenesis. USA Patent Application."},{"issue":"1","key":"4348_CR153","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1524-475X.2010.00642.x","volume":"19","author":"TN Demidova-Rice","year":"2011","unstructured":"Demidova-Rice TN, Geevarghese A, Herman IM (2011) Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro. Wound Repair Regen 19(1):59\u201370","journal-title":"Wound Repair Regen"},{"issue":"2","key":"4348_CR154","volume":"7","author":"TN Demidova-Rice","year":"2012","unstructured":"Demidova-Rice TN et al (2012) Human platelet-rich plasma-and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS\u00a0One 7(2):e32146","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"4348_CR155","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood-2002-12-3634","volume":"102","author":"T Licht","year":"2003","unstructured":"Licht T et al (2003) Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). Blood 102(6):2099\u20132107","journal-title":"Blood"},{"issue":"7","key":"4348_CR156","first-page":"3479","volume":"111","author":"S Soro","year":"2008","unstructured":"Soro S et al (2008) A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through \u03b15\u03b21 integrin. Blood J Am Soc Hematol 111(7):3479\u20133488","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"4348_CR157","first-page":"3014","volume":"101","author":"J-M Liu","year":"2003","unstructured":"Liu J-M et al (2003) The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood J Am Soc Hematol 101(8):3014\u20133020","journal-title":"Blood J Am Soc Hematol"},{"issue":"35","key":"4348_CR158","doi-asserted-by":"crossref","first-page":"31963","DOI":"10.1074\/jbc.M200082200","volume":"277","author":"N Gao","year":"2002","unstructured":"Gao N et al (2002) Vanadate-induced expression of hypoxia-inducible factor 1\u03b1 and vascular endothelial growth factor through phosphatidylinositol 3-kinase\/Akt pathway and reactive oxygen species. J Biol Chem 277(35):31963\u201331971","journal-title":"J Biol Chem"},{"issue":"1","key":"4348_CR159","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2008.01.020","volume":"264","author":"S Nishio","year":"2008","unstructured":"Nishio S et al (2008) Cap43\/NDRG1\/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 264(1):36\u201343","journal-title":"Cancer Lett"},{"issue":"1","key":"4348_CR160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/modpathol.3800711","volume":"20","author":"M-S Chua","year":"2007","unstructured":"Chua M-S et al (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20(1):76\u201383","journal-title":"Mod Pathol"},{"issue":"5","key":"4348_CR161","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/carcin\/bgl229","volume":"28","author":"SA Mousa","year":"2007","unstructured":"Mousa SA et al (2007) Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds. Carcinogenesis 28(5):962\u2013967","journal-title":"Carcinogenesis"},{"issue":"18","key":"4348_CR162","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1016\/j.biomaterials.2010.02.071","volume":"31","author":"AL Raines","year":"2010","unstructured":"Raines AL et al (2010) Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy. Biomaterials 31(18):4909\u20134917","journal-title":"Biomaterials"},{"issue":"1","key":"4348_CR163","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.actbio.2011.09.008","volume":"8","author":"W Zhai","year":"2012","unstructured":"Zhai W et al (2012) Silicate bioceramics induce angiogenesis during bone regeneration. Acta Biomater 8(1):341\u2013349","journal-title":"Acta Biomater"},{"issue":"6","key":"4348_CR164","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1016\/j.actbio.2013.02.014","volume":"9","author":"H Li","year":"2013","unstructured":"Li H, Chang J (2013) Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect. Acta Biomater 9(6):6981\u20136991","journal-title":"Acta Biomater"},{"issue":"31","key":"4348_CR165","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1016\/j.biomaterials.2012.07.019","volume":"33","author":"S Das","year":"2012","unstructured":"Das S et al (2012) The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials 33(31):7746\u20137755","journal-title":"Biomaterials"},{"issue":"5","key":"4348_CR166","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1165\/rcmb.2003-0426OC","volume":"31","author":"G Chachami","year":"2004","unstructured":"Chachami G et al (2004) Cobalt induces hypoxia-inducible factor-1\u03b1 expression in airway smooth muscle cells by a reactive oxygen species\u2014and PI3K-dependent mechanism. Am J Respir Cell Mol Biol Evol 31(5):544\u2013551","journal-title":"Am J Respir Cell Mol Biol Evol"},{"issue":"7","key":"4348_CR167","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00018-003-2370-y","volume":"60","author":"C Bracken","year":"2003","unstructured":"Bracken C, Whitelaw M, Peet D (2003) The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 60(7):1376\u20131393","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"4348_CR168","first-page":"413","volume":"10","author":"VS Bollu","year":"2016","unstructured":"Bollu VS et al (2016) Evaluation of in vivo cytogenetic toxicity of europium hydroxide nanorods (EHNs) in male and female Swiss albino mice. ACS Biomater Sci 10(4):413\u2013425","journal-title":"ACS Biomater Sci"},{"issue":"26","key":"4348_CR169","doi-asserted-by":"crossref","first-page":"21725","DOI":"10.1039\/C6RA01625A","volume":"6","author":"K Ge","year":"2016","unstructured":"Ge K et al (2016) Europium-doped NaYF 4 nanoparticles cause the necrosis of primary mouse bone marrow stromal cells through lysosome damage. RSC Adv 6(26):21725\u201321734","journal-title":"RSC Adv"},{"issue":"51","key":"4348_CR170","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","volume":"106","author":"A Papapetropoulos","year":"2009","unstructured":"Papapetropoulos A et al (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci 106(51):21972\u201321977","journal-title":"Proc Natl Acad Sci"},{"issue":"23","key":"4348_CR171","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","volume":"109","author":"C Coletta","year":"2012","unstructured":"Coletta C et al (2012) Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci 109(23):9161\u20139166","journal-title":"Proc Natl Acad Sci"},{"issue":"28","key":"4348_CR172","doi-asserted-by":"crossref","first-page":"26180","DOI":"10.1074\/jbc.M101188200","volume":"276","author":"CD Mao","year":"2001","unstructured":"Mao CD, Hoang P, DiCorleto PE (2001) Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. J Biol Chem 276(28):26180\u201326188","journal-title":"J Biol Chem"},{"issue":"12","key":"4348_CR173","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/acsbiomaterials.7b00457","volume":"3","author":"SK Nethi","year":"2017","unstructured":"Nethi SK et al (2017) Pro-angiogenic properties of terbium hydroxide nanorods: molecular mechanisms and therapeutic applications in wound healing. ACS Biomater Sci Eng Min J 3(12):3635\u20133645","journal-title":"ACS Biomater Sci Eng Min J"},{"key":"4348_CR174","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109801","volume":"103","author":"R Augustine","year":"2019","unstructured":"Augustine R et al (2019) Yttrium oxide nanoparticle loaded scaffolds with enhanced cell adhesion and vascularization for tissue engineering applications. Mater Sci Eng C 103:109801","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"4348_CR175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.1998.9617","volume":"252","author":"T Boehm","year":"1998","unstructured":"Boehm T et al (1998) Zinc-binding of endostatin is essential for its antiangiogenic activity. Biochem Biophys Res Commun 252(1):190\u2013194","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"4348_CR176","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1073\/pnas.95.18.10443","volume":"95","author":"Y-H Ding","year":"1998","unstructured":"Ding Y-H et al (1998) Zinc-dependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci 95(18):10443\u201310448","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"4348_CR177","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1089\/ars.2008.2043","volume":"10","author":"A Loboda","year":"2008","unstructured":"Loboda A et al (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10(10):1767\u20131812","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"4348_CR178","first-page":"153","volume":"6","author":"P Gullino","year":"1986","unstructured":"Gullino P (1986) Considerations on the mechanism of the angiogenic response. Anticancer Res 6(2):153\u2013158","journal-title":"Anticancer Res"},{"issue":"5","key":"4348_CR179","first-page":"1183","volume":"69","author":"KS Raju","year":"1982","unstructured":"Raju KS et al (1982) Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst 69(5):1183\u20131188","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"4348_CR180","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1073\/pnas.92.5.1307","volume":"92","author":"EC Kohn","year":"1995","unstructured":"Kohn EC et al (1995) Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci 92(5):1307\u20131311","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4348_CR181","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/BTER:85:1:23","volume":"85","author":"M Dzondo-Gadet","year":"2002","unstructured":"Dzondo-Gadet M et al (2002) Action of boron at the molecular level. Biol Trace Elem Res 85(1):23\u201333","journal-title":"Biol Trace Elem Res"},{"issue":"1\u20133","key":"4348_CR182","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2741\/1610","volume":"10","author":"D Bernardini","year":"2005","unstructured":"Bernardini D et al (2005) Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Front Biosci 10(1\u20133):1177\u20131182","journal-title":"Front Biosci"},{"issue":"3","key":"4348_CR183","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jeurceramsoc.2017.07.028","volume":"38","author":"V Miguez-Pacheco","year":"2018","unstructured":"Miguez-Pacheco V et al (2018) Development and characterization of niobium-releasing silicate bioactive glasses for tissue engineering applications. J Eur Ceram Soc 38(3):871\u2013876","journal-title":"J Eur Ceram Soc"},{"issue":"12","key":"4348_CR184","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.tibtech.2016.07.005","volume":"34","author":"A Malhotra","year":"2016","unstructured":"Malhotra A, Habibovic P (2016) Calcium phosphates and angiogenesis: implications and advances for bone regeneration. Trends Biotechnol 34(12):983\u2013992","journal-title":"Trends Biotechnol"},{"issue":"5\u20136","key":"4348_CR185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/ten.2005.11.835","volume":"11","author":"H-C Liang","year":"2005","unstructured":"Liang H-C et al (2005) Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration. Tissue Eng 11(5\u20136):835\u2013846","journal-title":"Tissue Eng"},{"issue":"3","key":"4348_CR186","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10456-005-9000-2","volume":"8","author":"PY Yue","year":"2005","unstructured":"Yue PY et al (2005) Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg 1 in vivo and in vitro. Angiogenesis 8(3):205\u2013216","journal-title":"Angiogenesis"},{"issue":"10","key":"4348_CR187","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.0000140676.88412.CF","volume":"110","author":"S Sengupta","year":"2004","unstructured":"Sengupta S et al (2004) Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110(10):1219\u20131225","journal-title":"Circulation"},{"issue":"5","key":"4348_CR188","first-page":"677","volume":"23","author":"SJ Hong","year":"2009","unstructured":"Hong SJ et al (2009) Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo. Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv 23(5):677\u2013686","journal-title":"Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv"},{"issue":"4","key":"4348_CR189","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11095-005-2500-3","volume":"22","author":"Y-C Huang","year":"2005","unstructured":"Huang Y-C et al (2005) A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharm Res 22(4):636\u2013646","journal-title":"Pharm Res"},{"issue":"3","key":"4348_CR190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mjt.0000212706.73410.57","volume":"13","author":"X Xin","year":"2006","unstructured":"Xin X et al (2006) Extraction of 20 (S)-ginsenoside Rg2 from cultured Panax notoginseng cells in vitro stimulates human umbilical cord vein endothelial cell proliferation. Am J Ther 13(3):205\u2013210","journal-title":"Am J Ther"},{"issue":"04","key":"4348_CR191","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2002-26750","volume":"68","author":"S Choi","year":"2002","unstructured":"Choi S et al (2002) Angiogenic activity of \u03b2-sitosterol in the ischaemia\/reperfusion-damaged brain of Mongolian gerbil. Planta Med 68(04):330\u2013335","journal-title":"Planta Med"},{"issue":"7","key":"4348_CR192","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s001099900019","volume":"77","author":"N Ferrara","year":"1999","unstructured":"Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77(7):527\u2013543","journal-title":"J Mol Med"},{"issue":"03","key":"4348_CR193","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1142\/S0192415X08005965","volume":"36","author":"H Meng","year":"2008","unstructured":"Meng H et al (2008) Angiogenic effects of the extracts from Chinese herbs: Angelica and Chuanxiong. Am J Chin Med 36(03):541\u2013554","journal-title":"Am J Chin Med"},{"issue":"1","key":"4348_CR194","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcb.21403","volume":"103","author":"HW Lam","year":"2008","unstructured":"Lam HW et al (2008) The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. J Cell Biochem 103(1):195\u2013211","journal-title":"J Cell Biochem"},{"issue":"9","key":"4348_CR195","first-page":"1205","volume":"23","author":"Y Zhang","year":"2009","unstructured":"Zhang Y et al (2009) Radix Astragali extract promotes angiogenesis involving vascular endothelial growth factor receptor-related phosphatidylinositol 3-kinase\/Akt-dependent pathway in human endothelial cells. Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv 23(9):1205\u20131213","journal-title":"Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv"},{"issue":"5","key":"4348_CR196","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/jf104018u","volume":"59","author":"KY Zheng","year":"2011","unstructured":"Zheng KY et al (2011) Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells: a signaling mediated via the accumulation of hypoxia-inducible factor-1\u03b1. J Agric Food Chem 59(5):1697\u20131704","journal-title":"J Agric Food Chem"},{"issue":"7\u20138","key":"4348_CR197","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.intimp.2009.04.001","volume":"9","author":"D-Y Choi","year":"2009","unstructured":"Choi D-Y et al (2009) Stimulatory effect of Cinnamomum cassia and cinnamic acid on angiogenesis through up-regulation of VEGF and Flk-1\/KDR expression. Int Immunopharmacol 9(7\u20138):959\u2013967","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"4348_CR198","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijcard.2010.10.021","volume":"156","author":"H Chen","year":"2012","unstructured":"Chen H et al (2012) Reconstitution of coronary vasculature in ischemic hearts by plant-derived angiogenic compounds. Int J Cardiol 156(2):148\u2013155","journal-title":"Int J Cardiol"},{"key":"4348_CR199","volume":"413","author":"Q Zhang","year":"2021","unstructured":"Zhang Q et al (2021) Tetrahedral framework nucleic acids act as antioxidants in acute kidney injury treatment. Chem Eng J 413:127426","journal-title":"Chem Eng J"},{"issue":"8","key":"4348_CR200","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/s41596-020-0355-z","volume":"15","author":"T Zhang","year":"2020","unstructured":"Zhang T et al (2020) Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment. Nat Protoc 15(8):2728\u20132757","journal-title":"Nat Protoc"},{"issue":"5","key":"4348_CR201","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1021\/acs.nanolett.0c00529","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020) Tetrahedral framework nucleic acids deliver antimicrobial peptides with improved effects and less susceptibility to bacterial degradation. Nano Lett 20(5):3602\u20133610","journal-title":"Nano Lett"},{"key":"4348_CR202","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.omtn.2019.12.034","volume":"19","author":"T Yoshitomi","year":"2020","unstructured":"Yoshitomi T et al (2020) Binding and structural properties of DNA aptamers with VEGF-A-mimic activity. Mol Ther Nucleic Acids 19:1145\u20131152","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"4348_CR203","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1021\/ac303023d","volume":"85","author":"Y Nonaka","year":"2013","unstructured":"Nonaka Y et al (2013) Affinity improvement of a VEGF aptamer by in silico maturation for a sensitive VEGF-detection system. Anal Chem 85(2):1132\u20131137","journal-title":"Anal Chem"},{"issue":"40","key":"4348_CR204","doi-asserted-by":"crossref","first-page":"44508","DOI":"10.1021\/acsami.0c13839","volume":"12","author":"D Zhao","year":"2020","unstructured":"Zhao D et al (2020) Tetrahedral framework nucleic acid promotes the treatment of bisphosphonate-related osteonecrosis of the jaws by promoting angiogenesis and M2 polarization. ACS Appl Mater Interfaces 12(40):44508\u201344522","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"4348_CR205","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1021\/acsami.0c00874","volume":"12","author":"S Lin","year":"2020","unstructured":"Lin S et al (2020) Antioxidative and angiogenesis-promoting effects of tetrahedral framework nucleic acids in diabetic wound healing with activation of the Akt\/Nrf2\/HO-1 pathway. ACS Appl Mater Interfaces 12(10):11397\u201311408","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"4348_CR206","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1021\/acsbiomaterials.9b01175","volume":"5","author":"O Juhl IV","year":"2019","unstructured":"Juhl O IV et al (2019) Aptamer-functionalized fibrin hydrogel improves vascular endothelial growth factor release kinetics and enhances angiogenesis and osteogenesis in critically sized cranial defects. ACS Biomater Sci Eng Min J 5(11):6152\u20136160","journal-title":"ACS Biomater Sci Eng Min J"},{"issue":"5","key":"4348_CR207","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/scientificamerican0509-64","volume":"300","author":"A Khademhosseini","year":"2009","unstructured":"Khademhosseini A, Vacanti JP, Langer R (2009) Progress in tissue engineering. Sci Am 300(5):64\u201371","journal-title":"Sci Am"},{"issue":"3","key":"4348_CR208","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.stem.2018.02.009","volume":"22","author":"H-HG Song","year":"2018","unstructured":"Song H-HG et al (2018) Vascular tissue engineering: progress, challenges, and clinical promise. Cell Stem Cell 22(3):340\u2013354","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4348_CR209","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/rme.09.77","volume":"5","author":"S Ravi","year":"2010","unstructured":"Ravi S, Chaikof EL (2010) Biomaterials for vascular tissue engineering. Regen Med 5(1):107\u2013120","journal-title":"Regen Med"},{"issue":"3","key":"4348_CR210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/ten.teb.2009.0085","volume":"15","author":"M Lovett","year":"2009","unstructured":"Lovett M et al (2009) Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 15(3):353\u2013370","journal-title":"Tissue Eng Part B Rev"},{"issue":"1","key":"4348_CR211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wsbm.1246","volume":"6","author":"S Li","year":"2014","unstructured":"Li S, Sengupta D, Chien S (2014) Vascular tissue engineering: from in vitro to in situ. Wiley Interdiscip Rev Syst Biol Med Glob Surviv 6(1):61\u201376","journal-title":"Wiley Interdiscip Rev Syst Biol Med Glob Surviv"},{"key":"4348_CR212","first-page":"376","volume":"7","author":"BB Leal","year":"2021","unstructured":"Leal BB et al (2021) Vascular tissue engineering: polymers and methodologies for small caliber vascular grafts. Front Cardiovasc Med 7:376","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"4348_CR213","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.biomaterials.2008.09.041","volume":"30","author":"Y Liu","year":"2009","unstructured":"Liu Y, Chan-Park MB (2009) Hydrogel based on interpenetrating polymer networks of dextran and gelatin for vascular tissue engineering. Biomaterials 30(2):196\u2013207","journal-title":"Biomaterials"},{"issue":"17","key":"4348_CR214","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/adfm.201000922","volume":"20","author":"H Ma","year":"2010","unstructured":"Ma H, Hu J, Ma PX (2010) Polymer scaffolds for small-diameter vascular tissue engineering. Adv Func Mater 20(17):2833\u20132841","journal-title":"Adv Func Mater"},{"issue":"2","key":"4348_CR215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108(2):153\u2013164","journal-title":"Cell"},{"issue":"10","key":"4348_CR216","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"R Kerbel","year":"2002","unstructured":"Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2(10):727\u2013739","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4348_CR217","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejim.2009.07.009","volume":"20","author":"N Makrilia","year":"2009","unstructured":"Makrilia N et al (2009) The role of angiogenesis in solid tumours: an overview. Eur J Intern Med 20(7):663\u2013671","journal-title":"Eur J Intern Med"},{"key":"4348_CR218","volume":"4","author":"Larry Gold","year":"2012","unstructured":"Gold L et al (2012) Aptamers and the RNA World, Past and Present. Cold Spring Harb Perspect Biol 4:a003582","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"4348_CR219","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.leukres.2008.11.019","volume":"33","author":"D Ribatti","year":"2009","unstructured":"Ribatti D (2009) Endogenous inhibitors of angiogenesis: a historical review. Leuk Res 33(5):638\u2013644","journal-title":"Leuk Res"},{"issue":"3","key":"4348_CR220","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0006-291X(91)91529-L","volume":"174","author":"M Kusaka","year":"1991","unstructured":"Kusaka M et al (1991) Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174(3):1070\u20131076","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"4348_CR221","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.92.17.7799","volume":"92","author":"SK Gupta","year":"1995","unstructured":"Gupta SK, Hassel T, Singh JP (1995) A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci 92(17):7799\u20137803","journal-title":"Proc Natl Acad Sci"},{"key":"4348_CR222","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-319-95228-4_19","volume-title":"Predictive biomarkers in oncology","author":"A Nasir","year":"2019","unstructured":"Nasir A (2019) Angiogenic signaling pathways and anti-angiogenic therapies in human cancer. Predictive biomarkers in oncology. Springer, New York, pp 243\u2013262"},{"key":"4348_CR223","volume":"125","author":"J Wu","year":"2020","unstructured":"Wu J et al (2020) Synergic effect of PD-1 blockade and endostar on the PI3K\/AKT\/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model. Biomed Pharmacother 125:109746","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4348_CR224","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O\u2019Reilly MS et al (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79(2):315\u2013328","journal-title":"Cell"},{"issue":"1\u20132","key":"4348_CR225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2004.11.063","volume":"228","author":"CJ Streck","year":"2005","unstructured":"Streck CJ et al (2005) Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Lett 228(1\u20132):163\u2013170","journal-title":"Cancer Lett"},{"key":"4348_CR226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41568-021-00363-z","volume":"21","author":"D Briukhovetska","year":"2021","unstructured":"Briukhovetska D et al (2021) Interleukins in cancer: from biology to therapy. Nat Rev Cancer 21:1\u201319","journal-title":"Nat Rev Cancer"},{"key":"4348_CR227","unstructured":"Lee G-R, Ahn M-R (2020) Inhibition of vascular endothelial growth factor-induced angiogenesis by bee products. Korean Society of Food and Nutrition, 430\u2013431"},{"issue":"5","key":"4348_CR228","first-page":"508","volume":"69","author":"F Goto","year":"1993","unstructured":"Goto F et al (1993) Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Investig J Tech Methods 69(5):508\u2013517","journal-title":"Lab Investig J Tech Methods"},{"key":"4348_CR229","volume":"207","author":"K Li","year":"2020","unstructured":"Li K, Tay FR, Yiu CKY (2020) The past, present and future perspectives of matrix metalloproteinase inhibitors. Pharmacol Ther Clin Risk Manag 207:107465","journal-title":"Pharmacol Ther Clin Risk Manag"},{"issue":"6398","key":"4348_CR230","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D et al (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843\u2013845","journal-title":"Nature"},{"issue":"7","key":"4348_CR231","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","volume":"87","author":"S Davis","year":"1996","unstructured":"Davis S et al (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87(7):1161\u20131169","journal-title":"Cell"},{"issue":"2","key":"4348_CR232","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yexcr.2005.03.021","volume":"307","author":"R Heljasvaara","year":"2005","unstructured":"Heljasvaara R et al (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307(2):292\u2013304","journal-title":"Exp Cell Res"},{"issue":"22","key":"4348_CR233","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1242\/jcs.00106","volume":"115","author":"N Ortega","year":"2002","unstructured":"Ortega N, Werb Z (2002) New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci 115(22):4201\u20134214","journal-title":"J Cell Sci"},{"issue":"4","key":"4348_CR234","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3322\/caac.20075","volume":"60","author":"KM Cook","year":"2010","unstructured":"Cook KM, Figg WD (2010) Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 60(4):222\u2013243","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4348_CR235","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejca.2005.02.017","volume":"41","author":"J Fayette","year":"2005","unstructured":"Fayette J, Soria J-C, Armand J-P (2005) Use of angiogenesis inhibitors in tumour treatment. Eur J Cancer 41(8):1109\u20131116","journal-title":"Eur J Cancer"},{"issue":"3","key":"4348_CR236","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2001.19.3.851","volume":"19","author":"K Margolin","year":"2001","unstructured":"Margolin K et al (2001) Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. J Clin Oncol 19(3):851\u2013856","journal-title":"J Clin Oncol"},{"key":"4348_CR237","unstructured":"Reichert J et al (2010) Development trends for peptide therapeutics. Peptide Therapeutics Foundation"},{"issue":"12","key":"4348_CR238","first-page":"779","volume":"12","author":"PM Saladin","year":"2009","unstructured":"Saladin PM, Zhang BD, Reichert JM (2009) Current trends in the clinical development of peptide therapeutics. IDrugs Investig Drugs J 12(12):779\u2013784","journal-title":"IDrugs Investig Drugs J"},{"issue":"4","key":"4348_CR239","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tibtech.2008.01.002","volume":"26","author":"SK Bhutia","year":"2008","unstructured":"Bhutia SK, Maiti TK (2008) Targeting tumors with peptides from natural sources. Trends Biotechnol 26(4):210\u2013217","journal-title":"Trends Biotechnol"},{"issue":"8","key":"4348_CR240","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/138920111796117300","volume":"12","author":"VE Rosca","year":"2011","unstructured":"Rosca VE et al (2011) Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol 12(8):1101\u20131116","journal-title":"Curr Pharm Biotechnol"},{"issue":"12","key":"4348_CR241","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.chembiol.2006.10.007","volume":"13","author":"J Thevenard","year":"2006","unstructured":"Thevenard J et al (2006) Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin. Chem Biol Philos 13(12):1307\u20131315","journal-title":"Chem Biol Philos"},{"issue":"12","key":"4348_CR242","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s11095-008-9643-y","volume":"25","author":"K Park","year":"2008","unstructured":"Park K et al (2008) Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth. Pharm Res 25(12):2786\u20132798","journal-title":"Pharm Res"},{"issue":"7","key":"4348_CR243","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/1078-0432.CCR-07-4530","volume":"14","author":"F Do\u00f1ate","year":"2008","unstructured":"Do\u00f1ate F et al (2008) Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth. Clin Cancer Res 14(7):2137\u20132144","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4348_CR244","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/annonc\/mdm140","volume":"18","author":"S Hariharan","year":"2007","unstructured":"Hariharan S et al (2007) Assessment of the biological and pharmacological effects of the \u03b1\u03bd\u03b23 and \u03b1\u03bd\u03b25 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors. Ann Oncol 18(8):1400\u20131407","journal-title":"Ann Oncol"},{"key":"4348_CR245","first-page":"5610","volume":"26","author":"DA Reardon","year":"2007","unstructured":"Reardon DA et al (2007) Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. Clin Oncol 26:5610\u20135617","journal-title":"Clin Oncol"},{"issue":"11","key":"4348_CR246","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1073\/pnas.0915141107","volume":"107","author":"RJ Giordano","year":"2010","unstructured":"Giordano RJ et al (2010) From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway. Proc Natl Acad Sci 107(11):5112\u20135117","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"4348_CR247","first-page":"5344","volume":"62","author":"JC Juarez","year":"2002","unstructured":"Juarez JC et al (2002) Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain. Can Res 62(18):5344\u20135350","journal-title":"Can Res"},{"issue":"4","key":"4348_CR248","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1158\/0008-5472.CAN-05-2217","volume":"66","author":"J Dixelius","year":"2006","unstructured":"Dixelius J et al (2006) Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Can Res 66(4):2089\u20132097","journal-title":"Can Res"},{"issue":"16","key":"4348_CR249","first-page":"4678","volume":"62","author":"Y Guo","year":"2002","unstructured":"Guo Y et al (2002) An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer. Can Res 62(16):4678\u20134684","journal-title":"Can Res"},{"issue":"15","key":"4348_CR250","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1073\/pnas.150239497","volume":"97","author":"K Mishima","year":"2000","unstructured":"Mishima K et al (2000) A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. Proc Natl Acad Sci 97(15):8484\u20138489","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"4348_CR251","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1021\/jm0401560","volume":"48","author":"F Haviv","year":"2005","unstructured":"Haviv F et al (2005) Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities. J Med Chem 48(8):2838\u20132846","journal-title":"J Med Chem"},{"issue":"8","key":"4348_CR252","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","volume":"13","author":"S Ni","year":"2020","unstructured":"Ni S et al (2020) Recent progress in aptamer discoveries and modifications for therapeutic applications. ACS Appl Mater Interfaces 13(8):9500\u20139519","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"4348_CR253","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/anie.202003563","volume":"60","author":"L Li","year":"2021","unstructured":"Li L et al (2021) Nucleic acid aptamers for molecular diagnostics and therapeutics: advances and perspectives. Angew Chem Int Ed 60(5):2221\u20132231","journal-title":"Angew Chem Int Ed"},{"issue":"8","key":"4348_CR254","doi-asserted-by":"crossref","first-page":"9491","DOI":"10.1021\/acsami.0c20707","volume":"13","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Immobilization strategies for enhancing sensitivity of electrochemical aptamer-based sensors. ACS Appl Mater Interfaces 13(8):9491\u20139499","journal-title":"ACS Appl Mater Interfaces"},{"key":"4348_CR255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fchem.2020.00434","volume":"8","author":"EM McConnell","year":"2020","unstructured":"McConnell EM, Nguyen J, Li Y (2020) Aptamer-based biosensors for environmental monitoring. Front Chem 8:434","journal-title":"Front Chem"},{"key":"4348_CR256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-019-10202-9","volume":"104","author":"FRW Schmitz","year":"2020","unstructured":"Schmitz FRW et al (2020) An overview and future prospects on aptamers for food safety. Appl Microbiol Biotechnol Adv 104:1\u201311","journal-title":"Appl Microbiol Biotechnol Adv"},{"issue":"4","key":"4348_CR257","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00253-005-0193-5","volume":"69","author":"D Proske","year":"2005","unstructured":"Proske D et al (2005) Aptamers\u2014basic research, drug development, and clinical applications. Appl Microbiol Biotechnol Adv 69(4):367\u2013374","journal-title":"Appl Microbiol Biotechnol Adv"},{"issue":"1","key":"4348_CR258","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1167\/iovs.01-1156","volume":"44","author":"KG Carrasquillo","year":"2003","unstructured":"Carrasquillo KG et al (2003) Controlled delivery of the anti-VEGF aptamer EYE001 with poly (lactic-co-glycolic) acid microspheres. Investig Ophthalmol Vis Sci 44(1):290\u2013299","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"4348_CR259","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1023\/A:1007657109012","volume":"17","author":"DW Drolet","year":"2000","unstructured":"Drolet DW et al (2000) Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res 17(12):1503\u20131510","journal-title":"Pharm Res"},{"issue":"19","key":"4348_CR260","first-page":"5476","volume":"62","author":"K Pietras","year":"2002","unstructured":"Pietras K et al (2002) Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Can Res 62(19):5476\u20135484","journal-title":"Can Res"},{"issue":"1","key":"4348_CR261","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ophtha.2015.09.004","volume":"123","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ et al (2016) A phase 1 study of intravitreous E10030 in combination with ranibizumab in neovascular age-related macular degeneration. Ophthalmology 123(1):78\u201385","journal-title":"Ophthalmology"},{"key":"4348_CR262","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.omtn.2019.07.018","volume":"17","author":"Y Matsuda","year":"2019","unstructured":"Matsuda Y et al (2019) Anti-angiogenic and anti-scarring dual action of an anti-fibroblast growth factor 2 aptamer in animal models of retinal disease. Mol Ther Nucleic Acids 17:819\u2013828","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"4348_CR263","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/cbt.9.3.10635","volume":"9","author":"C Lu","year":"2010","unstructured":"Lu C et al (2010) Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther 9(3):176\u2013182","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"4348_CR264","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/nat.2020.0875","volume":"30","author":"M Tezuka-Kagajo","year":"2020","unstructured":"Tezuka-Kagajo M et al (2020) Development of human CBF1-targeting single-stranded DNA aptamers with antiangiogenic activity in vitro. Nucleic Acid Ther 30(6):365\u2013378","journal-title":"Nucleic Acid Ther"},{"issue":"23","key":"4348_CR265","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1073\/pnas.90.23.11227","volume":"90","author":"D Jellinek","year":"1993","unstructured":"Jellinek D et al (1993) High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci 90(23):11227\u201311231","journal-title":"Proc Natl Acad Sci"},{"issue":"32","key":"4348_CR266","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.1074\/jbc.273.32.20556","volume":"273","author":"J Ruckman","year":"1998","unstructured":"Ruckman J et al (1998) 2\u2032-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165): Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273(32):20556\u201320567","journal-title":"J Biol Chem"},{"issue":"9","key":"4348_CR267","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.0831159100","volume":"100","author":"RR White","year":"2003","unstructured":"White RR et al (2003) Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci 100(9):5028\u20135033","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"4348_CR268","doi-asserted-by":"crossref","first-page":"2000337","DOI":"10.1002\/mabi.202000337","volume":"21","author":"T Roy","year":"2021","unstructured":"Roy T, James BD, Allen JB (2021) Anti-VEGF-R2 aptamer and RGD peptide synergize in a bifunctional hydrogel for enhanced angiogenic potential. Macromol Biosci 21(2):2000337","journal-title":"Macromol Biosci"},{"issue":"9","key":"4348_CR269","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0969-2126(98)00116-6","volume":"6","author":"YA Muller","year":"1998","unstructured":"Muller YA et al (1998) VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 \u00c5 resolution and mutational analysis of the interface. Structure 6(9):1153\u20131167","journal-title":"Structure"},{"issue":"1","key":"4348_CR270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1349-7006.1999.tb00671.x","volume":"90","author":"M Asano","year":"1999","unstructured":"Asano M, Yukita A, Suzuki H (1999) Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor. Jpn J Cancer Res 90(1):93\u2013100","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"4348_CR271","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/ijms19041232","volume":"19","author":"Y Itatani","year":"2018","unstructured":"Itatani Y et al (2018) Resistance to anti-angiogenic therapy in cancer\u2014alterations to anti-VEGF pathway. Int J Mol Sci 19(4):1232","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4348_CR272","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-200868040-00009","volume":"68","author":"PL McCormack","year":"2008","unstructured":"McCormack PL, Keam SJ (2008) Bevacizumab. Drugs Soc 68(4):487\u2013506","journal-title":"Drugs Soc"},{"key":"4348_CR273","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans S (2013) Nanobodies: natural single-domain antibodies. Annu Rev Biochem 82:775\u2013797","journal-title":"Annu Rev Biochem"},{"key":"4348_CR274","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3389\/fimmu.2017.01746","volume":"8","author":"R Arezumand","year":"2017","unstructured":"Arezumand R et al (2017) Nanobodies as novel agents for targeting angiogenesis in solid cancers. Front Immunol 8:1746","journal-title":"Front Immunol"},{"issue":"3","key":"4348_CR275","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tiv.2007.12.009","volume":"22","author":"J Woods","year":"2008","unstructured":"Woods J et al (2008) Direct antiangiogenic actions of cadmium on human vascular endothelial cells. Toxicol In Vitro 22(3):643\u2013651","journal-title":"Toxicol In Vitro"},{"key":"4348_CR276","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.lfs.2006.05.007","volume":"79","author":"W Prozialeck","year":"2006","unstructured":"Prozialeck W, Edwards JR, Woods JM (2006) The vascular endothelium as a target of cadmium toxicity. Life Sci 79:1493\u20131506","journal-title":"Life Sci"},{"issue":"14","key":"4348_CR277","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1039\/D0NR00631A","volume":"12","author":"S Das","year":"2020","unstructured":"Das S et al (2020) Anti-angiogenic vanadium pentoxide nanoparticles for the treatment of melanoma and their in vivo toxicity study. Nanoscale 12(14):7604\u20137621","journal-title":"Nanoscale"},{"issue":"3","key":"4348_CR278","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3892\/ol.2017.6518","volume":"14","author":"MH Yang","year":"2017","unstructured":"Yang MH et al (2017) Anti-angiogenic effect of arsenic trioxide in lung cancer via inhibition of endothelial cell migration, proliferation and tube formation. Oncol Lett 14(3):3103\u20133109","journal-title":"Oncol Lett"},{"issue":"5","key":"4348_CR279","doi-asserted-by":"crossref","first-page":"e1109","DOI":"10.1016\/j.nano.2014.02.007","volume":"10","author":"DH Jo","year":"2014","unstructured":"Jo DH et al (2014) Anti-angiogenic effect of bare titanium dioxide nanoparticles on pathologic neovascularization without unbearable toxicity. Nanomed Nanotechnol Biol Med Glob Surviv 10(5):e1109\u2013e1117","journal-title":"Nanomed Nanotechnol Biol Med Glob Surviv"},{"issue":"5","key":"4348_CR280","first-page":"784","volume":"8","author":"DH Jo","year":"2012","unstructured":"Jo DH et al (2012) Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor. Biomaterials 8(5):784\u2013791","journal-title":"Biomaterials"},{"issue":"7","key":"4348_CR281","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2010.11.030","volume":"32","author":"JH Kim","year":"2011","unstructured":"Kim JH et al (2011) The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation. Biomaterials 32(7):1865\u20131871","journal-title":"Biomaterials"},{"key":"4348_CR282","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acsbiomaterials.1c01268","volume":"8","author":"JM Yong","year":"2022","unstructured":"Yong JM et al (2022) ROS-mediated anti-angiogenic activity of cerium oxide nanoparticles in melanoma cells. ACS Biomater Sci Eng Min J 8:512\u2013525","journal-title":"ACS Biomater Sci Eng Min J"},{"key":"4348_CR283","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1024>3.0.CO;2-T","volume":"91","author":"K Norrby","year":"2001","unstructured":"Norrby K, Mattsby-Baltzer I, Innocenti M, Tuneberg S (2001) Orally administered bovine lactoferrin systemically inhibits VEGF-mediated angiogenesis in the rat. Int J Cancer 91:236\u2013240","journal-title":"Int J Cancer"},{"issue":"3","key":"4348_CR284","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.mvr.2009.07.001","volume":"78","author":"B Bussolati","year":"2009","unstructured":"Bussolati B et al (2009) Anti-angiogenic properties of calcium trifluoroacetate. Microvasc Res 78(3):272\u2013277","journal-title":"Microvasc Res"},{"issue":"1","key":"4348_CR285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbadis.2004.02.004","volume":"1689","author":"JA Maier","year":"2004","unstructured":"Maier JA et al (2004) High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta Mol Basis Dis 1689(1):6\u201312","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"33","key":"4348_CR286","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.2174\/138161207782360492","volume":"13","author":"H Ichikawa","year":"2007","unstructured":"Ichikawa H et al (2007) Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr Pharm Des 13(33):3400\u20133416","journal-title":"Curr Pharm Des"},{"key":"4348_CR287","doi-asserted-by":"crossref","unstructured":"Kruger EA et al (2001) Approaches to preclinical screening of antiangiogenic agents. In: Seminars in oncology. Elsevier, Amsterdam","DOI":"10.1016\/S0093-7754(01)90026-0"},{"issue":"sup201","key":"4348_CR288","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00365519009085798","volume":"50","author":"H Adlercreutz","year":"1990","unstructured":"Adlercreutz H (1990) Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Investig J Tech Methods 50(sup201):3\u201323","journal-title":"Scand J Clin Lab Investig J Tech Methods"},{"issue":"1","key":"4348_CR289","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-3-19","volume":"3","author":"MS Donaldson","year":"2004","unstructured":"Donaldson MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3(1):1\u201321","journal-title":"Nutr J"},{"issue":"3","key":"4348_CR290","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/138945006776054951","volume":"7","author":"C Neal","year":"2006","unstructured":"Neal C et al (2006) Clinical aspects of natural anti-angiogenic drugs. Curr Drug Targets 7(3):371\u2013383","journal-title":"Curr Drug Targets"},{"issue":"2","key":"4348_CR291","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/np030498t","volume":"67","author":"NH Oberlies","year":"2004","unstructured":"Oberlies NH, Kroll DJ (2004) Camptothecin and taxol: historic achievements in natural products research. J Nat Prod 67(2):129\u2013135","journal-title":"J Nat Prod"},{"issue":"6","key":"4348_CR292","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2006.04.006","volume":"27","author":"T-P Fan","year":"2006","unstructured":"Fan T-P et al (2006) Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 27(6):297\u2013309","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"4348_CR293","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","volume":"93","author":"MC Wani","year":"1971","unstructured":"Wani MC et al (1971) Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93(9):2325\u20132327","journal-title":"J Am Chem Soc"},{"issue":"2","key":"4348_CR294","first-page":"130","volume":"10","author":"D Kingston","year":"2007","unstructured":"Kingston D, Newman DJ (2007) Taxoids: cancer-fighting compounds from nature. Curr Opin Drug Discov Dev Change 10(2):130\u2013144","journal-title":"Curr Opin Drug Discov Dev Change"},{"issue":"1","key":"4348_CR295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01635589209514201","volume":"18","author":"G Block","year":"1992","unstructured":"Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18(1):1\u201329","journal-title":"Nutr Cancer"},{"issue":"4","key":"4348_CR296","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1569-9056(05)80156-3","volume":"3","author":"A Lekas","year":"2005","unstructured":"Lekas A et al (2005) 147Association of hypoxia inducible factor-1A (HIF-1A), vascular endothelial growth factor (VEGF) and angiogenesis in benign prostate hyperplasia. Eur Urol Suppl 3(4):39","journal-title":"Eur Urol Suppl"},{"issue":"16","key":"4348_CR297","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1021\/ja00968a057","volume":"88","author":"ME Wall","year":"1966","unstructured":"Wall ME et al (1966) Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata1, 2. J Am Chem Soc 88(16):3888\u20133890","journal-title":"J Am Chem Soc"},{"issue":"5","key":"4348_CR298","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002800050997","volume":"44","author":"MK Clements","year":"1999","unstructured":"Clements MK et al (1999) Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol Ther 44(5):411\u2013416","journal-title":"Cancer Chemother Pharmacol Ther"},{"issue":"44","key":"4348_CR299","doi-asserted-by":"crossref","first-page":"1904278","DOI":"10.1002\/adma.201904278","volume":"31","author":"J Jiang","year":"2019","unstructured":"Jiang J et al (2019) Combretastatin A4 nanodrug-induced MMP9 amplification boosts tumor-selective release of doxorubicin prodrug. Adv Mater 31(44):1904278","journal-title":"Adv Mater"},{"issue":"9","key":"4348_CR300","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/13543776.2019.1651841","volume":"29","author":"LM Nainwal","year":"2019","unstructured":"Nainwal LM et al (2019) Combretastatin-based compounds with therapeutic characteristics: a patent review. Expert Opin Ther Pat 29(9):703\u2013731","journal-title":"Expert Opin Ther Pat"},{"issue":"8","key":"4348_CR301","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1039\/C7MD00227K","volume":"8","author":"ZS Seddigi","year":"2017","unstructured":"Seddigi ZS et al (2017) Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents. MedChemComm 8(8):1592\u20131603","journal-title":"MedChemComm"},{"issue":"7","key":"4348_CR302","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1073\/pnas.90.7.2690","volume":"90","author":"T Fotsis","year":"1993","unstructured":"Fotsis T et al (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci 90(7):2690\u20132694","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4348_CR303","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01646-5","volume":"21","author":"Z Javed","year":"2021","unstructured":"Javed Z et al (2021) Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. Cancer Cell Int 21(1):1\u201312","journal-title":"Cancer Cell Int"},{"issue":"2","key":"4348_CR304","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-020-01009-8","volume":"41","author":"J Guo","year":"2021","unstructured":"Guo J et al (2021) Involvement of \u03b17nAChR in the protective effects of genistein against \u03b2-amyloid-induced oxidative stress in neurons via a PI3K\/Akt\/Nrf2 pathway-related mechanism. Cell Mol Neurobiol 41(2):377\u2013393","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"4348_CR305","first-page":"49","volume":"40","author":"O Kucuk","year":"2020","unstructured":"Kucuk O (2020) Genistein in prostate cancer prevention and treatment. Multidiscip Digit Publ Inst Proc 40(1):49","journal-title":"Multidiscip Digit Publ Inst Proc"},{"issue":"5","key":"4348_CR306","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1081\/CNV-120023773","volume":"21","author":"FH Sarkar","year":"2003","unstructured":"Sarkar FH, Li YJ (2003) Soy isoflavones and cancer prevention: clinical science review. Cancer Investig 21(5):744\u2013757","journal-title":"Cancer Investig"},{"issue":"7","key":"4348_CR307","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/ijc.21545","volume":"118","author":"SK Rodriguez","year":"2006","unstructured":"Rodriguez SK et al (2006) Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer Prev 118(7):1635\u20131644","journal-title":"Int J Cancer Prev"},{"issue":"2","key":"4348_CR308","first-page":"381","volume":"62","author":"S Lamy","year":"2002","unstructured":"Lamy S, Gingras D, B\u00e9liveau R (2002) Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Can Res 62(2):381\u2013385","journal-title":"Can Res"},{"issue":"1","key":"4348_CR309","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1254\/jphs.94.81","volume":"94","author":"B-C Lee","year":"2004","unstructured":"Lee B-C et al (2004) The inhibitory effects of aqueous extract of Magnolia officinalis on human mesangial cell proliferation by regulation of platelet-derived growth factor-BB and transforming growth factor-\u03b21 expression. J Pharmacol Sci 94(1):81\u201385","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"4348_CR310","first-page":"141","volume":"7","author":"P Lv","year":"2020","unstructured":"Lv P et al (2020) Tea polyphenols inhibit the growth and angiogenesis of breast cancer xenografts in a mouse model. J Trad Chin Med Sci 7(2):141\u2013147","journal-title":"J Trad Chin Med Sci"},{"issue":"8","key":"4348_CR311","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10815-019-01461-6","volume":"36","author":"M Bahramrezaie","year":"2019","unstructured":"Bahramrezaie M et al (2019) Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. J Assist Reprod Genet 36(8):1701\u20131712","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"4348_CR312","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/molecules25061412","volume":"25","author":"T Sudha","year":"2020","unstructured":"Sudha T et al (2020) Resveratrol and its nanoformulation attenuate growth and the angiogenesis of xenograft and orthotopic colon cancer models. Molecules 25(6):1412","journal-title":"Molecules"},{"issue":"1","key":"4348_CR313","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/CBB:44:1:043","volume":"44","author":"S Fukuda","year":"2006","unstructured":"Fukuda S et al (2006) Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 44(1):43\u201349","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"4348_CR314","first-page":"99","volume":"113","author":"J Zou","year":"2000","unstructured":"Zou J et al (2000) Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J 113(2):99\u2013102","journal-title":"Chin Med J"},{"issue":"6","key":"4348_CR315","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/152308601317203567","volume":"3","author":"KP Bhat","year":"2001","unstructured":"Bhat KP, Kosmeder JW, Pezzuto JM (2001) Biological effects of resveratrol. Antioxid Redox Signal 3(6):1041\u20131064","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"4348_CR316","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1159\/000363026","volume":"34","author":"R Guo","year":"2014","unstructured":"Guo R et al (2014) Resveratrol suppresses oxidised low-density lipoprotein-induced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the p38 MAPK pathway. Cell Physiol Biochem 34(2):603\u2013616","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"4348_CR317","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2010.05843.x","volume":"1215","author":"G Petrovski","year":"2011","unstructured":"Petrovski G, Gurusamy N, Das DK (2011) Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 1215(1):22\u201333","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4348_CR318","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.sjbs.2015.06.021","volume":"23","author":"X Liu","year":"2016","unstructured":"Liu X et al (2016) The effect and action mechanism of resveratrol on the vascular endothelial cell by high glucose treatment. Saudi J Biol Sci 23(1):S16\u2013S21","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"4348_CR319","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0006-291X(02)02306-9","volume":"297","author":"AE Gururaj","year":"2002","unstructured":"Gururaj AE et al (2002) Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297(4):934\u2013942","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4348_CR320","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF03401744","volume":"4","author":"JL Arbiser","year":"1998","unstructured":"Arbiser JL et al (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4(6):376\u2013383","journal-title":"Mol Med"},{"issue":"2","key":"4348_CR321","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.otohns.2004.09.006","volume":"132","author":"A Khafif","year":"2005","unstructured":"Khafif A et al (2005) Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132(2):317\u2013321","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"4348_CR322","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2005.04.044","volume":"331","author":"S Sen","year":"2005","unstructured":"Sen S, Sharma H, Singh N (2005) Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 331(4):1245\u20131252","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"4348_CR323","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1002\/slct.202101792","volume":"6","author":"N Upadhyay","year":"2021","unstructured":"Upadhyay N et al (2021) Recent anti-angiogenic drug discovery efforts to combat cancer. ChemistrySelect 6(23):5689\u20135700","journal-title":"ChemistrySelect"},{"issue":"6","key":"4348_CR324","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jare.2017.06.006","volume":"8","author":"AM Al-Abd","year":"2017","unstructured":"Al-Abd AM et al (2017) Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies\u2014a review. J Adv Res 8(6):591\u2013605","journal-title":"J Adv Res"},{"key":"4348_CR325","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1161\/01.CIR.102.5.579","volume":"102","author":"DJ Cohen","year":"2000","unstructured":"Cohen DJ, Giordano FJ, Hammond HK, Uham RX, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengartt TK (2000) Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102:E73-86","journal-title":"Circulation"},{"issue":"10","key":"4348_CR326","doi-asserted-by":"crossref","first-page":"e2020425","DOI":"10.1001\/jamanetworkopen.2020.20425","volume":"3","author":"B Chibaudel","year":"2020","unstructured":"Chibaudel B et al (2020) Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: a secondary analysis of the AVANT trial. JAMA Netw Open 3(10):e2020425\u2013e2020425","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4348_CR327","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2006.02.007","volume":"59","author":"G de Castro Junior","year":"2006","unstructured":"de Castro Junior G et al (2006) Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the \u201cdo ut des\u201d paradigm). Crit Rev Oncol Hematol 59(1):40\u201350","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"4348_CR328","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.2005.10.022","volume":"23","author":"G Casparini","year":"2005","unstructured":"Casparini G et al (2005) Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and other questions. J Clin Oncol 23(6):1295\u20131311","journal-title":"J Clin Oncol"},{"issue":"9","key":"4348_CR329","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMsa042220","volume":"352","author":"E Horstmann","year":"2005","unstructured":"Horstmann E et al (2005) Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med 352(9):895\u2013904","journal-title":"N Engl J Med"},{"issue":"23","key":"4348_CR330","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335\u20132342","journal-title":"N Engl J Med"},{"issue":"16","key":"4348_CR331","first-page":"3706","volume":"23","author":"FF Kabbinavar","year":"2005","unstructured":"Kabbinavar FF et al (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil\/leucovorin improves survival for patients with metastatic colorectal cancer. Eur J Cancer 23(16):3706\u20133712","journal-title":"Eur J Cancer"},{"issue":"9","key":"4348_CR332","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejca.2004.11.025","volume":"41","author":"V D\u2019Hondt","year":"2005","unstructured":"D\u2019Hondt V et al (2005) Will the dark sky over advanced renal cell carcinoma soon become brighter? Eur J Cancer 41(9):1246\u20131253","journal-title":"Eur J Cancer"},{"issue":"16_suppl","key":"4348_CR333","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/jco.2005.23.16_suppl.lba4510","volume":"23","author":"B Escudier","year":"2005","unstructured":"Escudier B et al (2005) Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43\u20139006) in patients with advanced renal cell carcinoma (RCC). J Clin Oncol 23(16_suppl):4510\u20134510","journal-title":"J Clin Oncol"},{"issue":"2","key":"4348_CR334","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCRESAHA.120.316851","volume":"127","author":"G Eelen","year":"2020","unstructured":"Eelen G et al (2020) Basic and therapeutic aspects of angiogenesis updated. Circ Res 127(2):310\u2013329","journal-title":"Circ Res"},{"issue":"8","key":"4348_CR335","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV (2017) Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer 17(8):457\u2013474","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4348_CR336","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B et al (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7(3):339","journal-title":"Adv Pharm Bull"},{"issue":"11","key":"4348_CR337","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1096\/fj.201700336R","volume":"31","author":"CH Liu","year":"2017","unstructured":"Liu CH et al (2017) Animal models of ocular angiogenesis: from development to pathologies. FASEB J 31(11):4665\u20134681","journal-title":"FASEB J"},{"key":"4348_CR338","doi-asserted-by":"crossref","unstructured":"Kleinman HK, Martin, GR (2005) Matrigel: basement membrane matrix with biological activity. In: Seminars in cancer biology. Elsevier, Amsterdam","DOI":"10.1016\/j.semcancer.2005.05.004"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04348-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04348-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04348-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T14:56:16Z","timestamp":1700664976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04348-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":338,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4348"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04348-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors give their consents for the publication of contents of this paper to be published in the Cellular and Molecular Life Sciences.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"349"}}